OnKure Therapeutics (OKUR) Interest Income - Net (2024 - 2026)

OnKure Therapeutics (OKUR) has 3 years of Interest Income - Net data on file, last reported at $458000.0 in Q1 2026.

• Quarterly Interest Income - Net fell 57.4% year-over-year to $458000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.8 million (up 13.0% YoY) and the FY2025 annual result came in at $3.4 million, up 100.41% from the prior year.
• Interest Income - Net fell to $458000.0 in Q1 2026, from $622000.0 in the prior quarter.
• In the past five years, Interest Income - Net ranged from a high of $1.3 million in Q4 2024 to a low of -$44000.0 in Q3 2024.
• A 3-year average of $616666.7 and a median of $622000.0 in 2025 frame the typical range for Interest Income - Net.
• Annual changes were most pronounced in 2025 — Interest Income - Net jumped 1922.73% — and 2026, when it slumped 57.4%.
• Tracing OKUR's Interest Income - Net over 3 years: stood at $1.3 million in 2024, then slumped by 50.52% to $622000.0 in 2025, then dropped by 26.37% to $458000.0 in 2026.
• The last three Interest Income - Net figures came in at $458000.0 (Q1 2026), $622000.0 (Q4 2025), and $802000.0 (Q3 2025), per Business Quant data.